Angiodynamics INC Schedule 13G passive stakes

The Vanguard Group has filed an amendment to its Schedule 13G for AngioDynamics Inc., reporting 0% beneficial ownership due to an internal corporate realignment.

Divisadero Street Capital Management and related entities filed an amendment to their Schedule 13G, disclosing a passive beneficial ownership of 0.01% in AngioDynamics, Inc. common stock as of December 31, 2025.

Systematic Financial Management LP has disclosed a 6.05% beneficial ownership stake in AngioDynamics Inc., signaling increased institutional interest.

Kevin Kotler has reported a 5.9% beneficial ownership stake in AngioDynamics, Inc., holding 2,421,526 shares of common stock.

Millennium Management LLC and affiliated entities have filed an amended Schedule 13G, disclosing their passive beneficial ownership of AngioDynamics, Inc. common stock as of December 31, 2025.

Point72 Asset Management, along with its affiliates and Steven A. Cohen, has disclosed a 6.2% beneficial ownership stake in AngioDynamics Inc., totaling 2,559,389 shares.

Armistice Capital, LLC and Steven Boyd have reported a 3.76% beneficial ownership stake in AngioDynamics Inc., totaling 1,527,815 shares.

Divisadero Street Capital Management and affiliates report an 8.4% beneficial ownership stake in AngioDynamics, Inc. common stock.

Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander have jointly disclosed beneficial ownership exceeding 5% of AngioDynamics, Inc.'s common stock.

Point72 Asset Management, Point72 Capital Advisors Inc., and Steven A. Cohen have jointly disclosed a passive beneficial ownership of 5.2% in AngioDynamics Inc.'s common stock.

Divisadero Street Capital Management, LP and its affiliates have reported a passive beneficial ownership of 5.3% in AngioDynamics, Inc.'s common stock.

Armistice Capital, LLC and its managing member Steven Boyd have jointly disclosed a beneficial ownership of 5.16% in AngioDynamics Inc.'s common stock, totaling 2,094,000 shares.

BlackRock, Inc. has filed an Amendment No. 8 to Schedule 13G, disclosing a 7.2% passive beneficial ownership stake in AngioDynamics Inc. as of March 31, 2025.

Millennium Management LLC and its affiliates have reported a 3.1% passive ownership stake in AngioDynamics, Inc., holding 1,239,572 shares of common stock.

Systematic Financial Management LP has filed an amended Schedule 13G, reporting a beneficial ownership of 6.15% in AngioDynamics Inc. as of December 31, 2024.

Systematic Financial Management LP has reported a passive beneficial ownership of 6.15% in AngioDynamics Inc., holding 2,521,066 shares as of February 13, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, revealing its beneficial ownership of 9.7% of AngioDynamics Inc.'s common stock as of December 31, 2024.